company background image
LCDX logo

Caliber Imaging & Diagnostics OTCPK:LCDX Stock Report

Last Price

US$0.0001

Market Cap

US$857.0

7D

0%

1Y

n/a

Updated

26 Mar, 2024

Data

Company Financials

Caliber Imaging & Diagnostics, Inc.

OTCPK:LCDX Stock Report

Market Cap: US$857.0

LCDX Stock Overview

Caliber Imaging & Diagnostics, Inc., a medical technologies company, designs, develops, and markets imaging solutions that shows tissue at the cellular level in the United States.

LCDX fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health0/6
Dividends0/6

Caliber Imaging & Diagnostics, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Caliber Imaging & Diagnostics
Historical stock prices
Current Share PriceUS$0.0001
52 Week HighUS$0.05
52 Week LowUS$0.0001
Beta0
1 Month Change0%
3 Month Change0%
1 Year Changen/a
3 Year Change-99.98%
5 Year Change-99.98%
Change since IPO-100.00%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

LCDXUS Medical EquipmentUS Market
7D0%-0.2%0.6%
1Yn/a12.0%29.5%

Return vs Industry: Insufficient data to determine how LCDX performed against the US Medical Equipment industry.

Return vs Market: Insufficient data to determine how LCDX performed against the US Market.

Price Volatility

Is LCDX's price volatile compared to industry and market?
LCDX volatility
LCDX Average Weekly Movementn/a
Medical Equipment Industry Average Movement7.8%
Market Average Movement6.0%
10% most volatile stocks in US Market16.9%
10% least volatile stocks in US Market3.0%

Stable Share Price: LCDX has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine LCDX's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
1991n/aL. Honehttps://www.caliberid.com

Caliber Imaging & Diagnostics, Inc., a medical technologies company, designs, develops, and markets imaging solutions that shows tissue at the cellular level in the United States. The company provides VivaScope 1500, a reflectance confocal imaging system that enables clinicians and researchers to capture confocal images that depict cellular structures of living tissue; and VivaScope 3000, a hand-held in vivo reflectance confocal microscope for skin imaging. It also offers VivaScan software to schedule patients for examinations, perform imaging examinations on one or more lesions during a visit, review, and report on images obtained during an examination, as well as VivaNet, a digital telepathology system.

Caliber Imaging & Diagnostics, Inc. Fundamentals Summary

How do Caliber Imaging & Diagnostics's earnings and revenue compare to its market cap?
LCDX fundamental statistics
Market capUS$857.00
Earnings (TTM)-US$6.25m
Revenue (TTM)US$3.14m

0.0x

P/S Ratio

0.0x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
LCDX income statement (TTM)
RevenueUS$3.14m
Cost of RevenueUS$2.65m
Gross ProfitUS$486.00k
Other ExpensesUS$6.74m
Earnings-US$6.25m

Last Reported Earnings

Mar 31, 2014

Next Earnings Date

n/a

Earnings per share (EPS)0
Gross Margin0.00%
Net Profit Margin0.00%
Debt/Equity Ratio0.0%

How did LCDX perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.